BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27056423)

  • 21. P2Y12 Reaction Units: Effect on Hemorrhagic and Thromboembolic Complications in Patients With Cerebral Aneurysms Treated With the Pipeline Embolization Device.
    Daou B; Starke RM; Chalouhi N; Barros G; Tjoumakaris S; Rosenwasser RH; Jabbour P
    Neurosurgery; 2016 Jan; 78(1):27-33. PubMed ID: 26571145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing and nature of in-house postoperative events following uncomplicated elective endovascular aneurysm treatment.
    Arias EJ; Patel B; Cross DT; Moran CJ; Dacey RG; Zipfel GJ; Derdeyn CP
    J Neurosurg; 2014 Nov; 121(5):1063-70. PubMed ID: 25170666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet drug resistance did not increase the thromboembolic events after stent-assisted coiling of unruptured intracranial aneurysm: a single center experience of 99 cases.
    Song J; Shin YS
    Neurol Sci; 2017 May; 38(5):879-885. PubMed ID: 28233076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of size ratio on thromboembolic events based on diffusion-weighted imaging after coil embolization for unruptured basilar apex aneurysm.
    Suzuki R; Takigawa T; Nagaishi M; Hyodo A; Suzuki K
    Clin Neurol Neurosurg; 2023 May; 228():107699. PubMed ID: 37023486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of antiplatelet therapy in aneurysm coiling.
    Rahme RJ; Zammar SG; El Ahmadieh TY; El Tecle NE; Ansari SA; Bendok BR
    Neurol Res; 2014 Apr; 36(4):383-8. PubMed ID: 24617939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative Light Transmission Aggregometry Values Predict for Thromboembolic Complications After Stent-Assisted Coil Embolization.
    Kan I; Ishibashi T; Sakuta K; Fujimura S; Yuki I; Kaku S; Kodama T; Kato N; Nishimura K; Aoki K; Sasaki Y; Karagiozov K; Murayama Y
    World Neurosurg; 2020 Feb; 134():e731-e738. PubMed ID: 31704360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Resistance to antiplatelet agents assessed by a point-of-care platelet function test and thromboembolic adverse events in neurointervention].
    Haraguchi K; Miyachi S; Izumi T; Matsubara N; Naito T; Asai T; Yamanouchi T; Wakabayashi T
    No Shinkei Geka; 2012 May; 40(5):399-406. PubMed ID: 22538281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stent-Assisted Coil Embolization of Intracranial Aneurysms: Complications in Acutely Ruptured versus Unruptured Aneurysms.
    Bechan RS; Sprengers ME; Majoie CB; Peluso JP; Sluzewski M; van Rooij WJ
    AJNR Am J Neuroradiol; 2016 Mar; 37(3):502-7. PubMed ID: 26405089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of thromboembolism during coil embolization in patients with unruptured intracranial aneurysm.
    Jo KI; Yeon JY; Kim KH; Jeon P; Kim JS; Hong SC
    Acta Neurochir (Wien); 2013 Jun; 155(6):1101-6. PubMed ID: 23624636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Preprocedural Platelet Function Testing on Periprocedural Complication Rates Associated With Pipeline Flow Diversion: An International Multicenter Study.
    Vranic JE; Dmytriw AA; Berglar IK; Alotaibi NM; Cancelliere NM; Stapleton CJ; Rabinov JD; Harker P; Gupta R; Bernstock JD; Koch MJ; Raymond SB; Mascitelli JR; Patterson TT; Seinfeld J; White A; Case D; Roark C; Gandhi CD; Al-Mufti F; Cooper J; Matouk C; Sujijantarat N; Devia DA; Ocampo-Navia MI; Villamizar-Torres DE; Puentes JC; Salem MM; Baig A; El Namaani K; Kühn AL; Pukenas B; Jankowitz BT; Burkhardt JK; Siddiqui A; Jabbour P; Singh J; Puri AS; Regenhardt RW; Mendes Pereira V; Patel AB
    Neurosurgery; 2024 Jul; 95(1):179-185. PubMed ID: 38634693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of P2Y
    Bohan CO; Wirtz MM; Hendrix P; Goren O; Schirmer CM; Islak C; Grassi DM; Dalal S; Weiner G; Griessenauer CJ
    World Neurosurg; 2020 Oct; 142():e445-e452. PubMed ID: 32688033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
    Siasos G; Oikonomou E; Zaromitidou M; Kioufis S; Kokkou E; Mourouzis K; Vlasis K; Vavuranakis M; Stone PH; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Sep; 242(1):102-8. PubMed ID: 26188531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet therapy for prevention of thromboembolic complications in coiling-only procedures for unruptured brain aneurysms.
    Almekhlafi MA; Al Sultan AS; Kuczynski AM; Brinjikji W; Menon BK; Hill MD; Goyal M
    J Neurointerv Surg; 2020 Mar; 12(3):298-302. PubMed ID: 31540948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    AJNR Am J Neuroradiol; 2014 Jan; 35(1):128-35. PubMed ID: 23828107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms.
    Kono K; Shintani A; Yoshimura R; Okada H; Tanaka Y; Fujimoto T; Tomura N; Terada T
    Acta Neurochir (Wien); 2013 Aug; 155(8):1549-57. PubMed ID: 23715948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for coil protrusion into the parent artery and associated thrombo-embolic events following unruptured cerebral aneurysm embolization.
    Ishihara H; Ishihara S; Niimi J; Neki H; Kakehi Y; Uemiya N; Kohyama S; Yamane F
    Interv Neuroradiol; 2015 Apr; 21(2):178-83. PubMed ID: 25964443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
    Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microembolism after endovascular coiling of unruptured cerebral aneurysms: incidence and risk factors.
    Park JC; Lee DH; Kim JK; Ahn JS; Kwun BD; Kim DY; Choi CG
    J Neurosurg; 2016 Mar; 124(3):777-83. PubMed ID: 26381257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Uhry S; Bessereau J; Camoin-Jau L; Paganelli F; Bonello L
    Hosp Pract (1995); 2012 Apr; 40(2):104-17. PubMed ID: 22615085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication.
    Petrov A; Rentsenkhuu G; Nota B; Ganzorig E; Regzengombo B; Jagusch S; Henkes E; Henkes H
    Interv Neuroradiol; 2021 Feb; 27(1):42-50. PubMed ID: 32640858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.